We are live on ! Find out more
SFI

Susquehanna Fundamental Investments Portfolio holdings

AUM $2.67B
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
+29.86%
1 Year Est. Return
+21.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$2.14B
Cap. Flow
+$1.33B
Cap. Flow %
24.32%
Top 10 Hldgs %
9.5%
Holding
1,686
New
336
Increased
688
Reduced
322
Closed
213

Top Buys

Rank Stock Value
1
DELL icon
Dell
DELL
+$46M
2
AEP icon
American Electric Power
AEP
+$21.2M
3
MRK icon
Merck
MRK
+$20.2M
4
CB icon
Chubb
CB
+$18M
5
CHD icon
Church & Dwight Co
CHD
+$17.8M

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$51.3M
2
BAC icon
Bank of America
BAC
+$19.6M
3
TXN icon
Texas Instruments
TXN
+$15.3M
4
CMS icon
CMS Energy
CMS
+$13.5M
5
WMB icon
Williams Companies
WMB
+$13.1M

Sector Composition

Rank Sector Weight
1 Technology 15.45%
2 Healthcare 13.52%
3 Industrials 13.18%
4 Financials 12.58%
5 Consumer Discretionary 11.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POWW icon
1426
Outdoor Holding Co
POWW
$267M
$94K ﹤0.01%
+28,339
New +$90.7K
AQB icon
1427
AquaBounty Technologies
AQB
$7.1M
$92K ﹤0.01%
525
– –
PIXY
1428
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$91K ﹤0.01%
1
-1
-50% -$90.7K
OLOX
1429
Olenox Industries
OLOX
$4.4M
$90K ﹤0.01%
2
-5
-71% -$90.6K
TLSA icon
1430
Tiziana Life Sciences
TLSA
$126M
$90K ﹤0.01%
44,566
-6,200
-12% -$19.6K
GMDA
1431
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$90K ﹤0.01%
10,700
– –
ZYNE
1432
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$90K ﹤0.01%
27,336
-31,032
-53% -$118K
BLPH
1433
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$88K ﹤0.01%
13,185
-1,315
-9% -$10.8K
OPGN
1434
DELISTED
OpGen, Inc
OPGN
$85K ﹤0.01%
209
+28
+15% +$11.6K
CTIC
1435
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$82K ﹤0.01%
+25,597
New +$85.1K
CARV
1436
DELISTED
Carver Bancorp
CARV
$81K ﹤0.01%
12,500
-4,700
-27% -$31.8K
AVXL icon
1437
Anavex Life Sciences
AVXL
$316M
$74K ﹤0.01%
13,633
-15,100
-53% -$79.6K
CANG
1438
Cango Inc
CANG
$89.8M
$72K ﹤0.01%
+1,030
New +$67.5K
NAVB
1439
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$71K ﹤0.01%
32,822
-18,826
-36% -$44.4K
ASX icon
1440
ASE Group
ASX
$102B
$70K ﹤0.01%
12,049
-26,383
-69% -$132K
IBIO icon
1441
iBio
IBIO
$73M
$70K ﹤0.01%
133
-59
-31% -$48.1K
XERS icon
1442
Xeris Biopharma Holdings
XERS
$1.55B
$70K ﹤0.01%
+14,132
New +$70.7K
BKCC
1443
DELISTED
BlackRock Capital Investment Corporation
BKCC
$70K ﹤0.01%
26,018
-25,659
-50% -$69K
ETTX
1444
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$69K ﹤0.01%
+27,977
New +$55K
ECOR icon
1445
electroCore
ECOR
$84.7M
$67K ﹤0.01%
2,874
-1,103
-28% -$27.2K
QCLS
1446
Q/C Technologies Inc
QCLS
$22.7M
$62K ﹤0.01%
5
-2
-29% -$24.5K
OXSQ icon
1447
Oxford Square Capital
OXSQ
$166M
$60K ﹤0.01%
19,713
-23,587
-54% -$66.7K
VTVT icon
1448
vTv Therapeutics
VTVT
$125M
$59K ﹤0.01%
+789
New +$60.5K
ONCT
1449
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$59K ﹤0.01%
+600
New +$38K
YELL
1450
DELISTED
Yellow Corporation Common Stock
YELL
$56K ﹤0.01%
+12,629
New +$61.2K
56 57
58
59 60

Similar funds

TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return

Susquehanna Fundamental Investments's Q4 2020 Portfolio in Review

As of Q4 2020, Susquehanna Fundamental Investments held 1,686 positions worth $5.49B, up 64% from $3.35B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Susquehanna Fundamental Investments deployed $1.33B of net new capital in Q4 2020, opening 336 new positions and adding to 688 existing holdings. Its largest new stake was American Electric Power: 244,155 shares worth $20.3M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was T-Mobile US, an estimated $51.3M trimmed.

  • Susquehanna Fundamental Investments's largest Q4 2020 buy was American Electric Power: 244,155 shares worth $20.3M.
  • Susquehanna Fundamental Investments added most to Dell in Q4 2020, an estimated $46M increase.
  • Susquehanna Fundamental Investments's biggest Q4 2020 reduction was T-Mobile US, cutting an estimated $51.3M.
  • Susquehanna Fundamental Investments fully exited Bank of America in Q4 2020, selling an estimated $19.6M.
  • Susquehanna Fundamental Investments's ten largest holdings make up 9.5% of its $5.49B portfolio in Q4 2020.
  • Susquehanna Fundamental Investments opened 336 new positions and closed 213 in Q4 2020.
  • Susquehanna Fundamental Investments's portfolio value rose 64% quarter-over-quarter to $5.49B.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2020, filed 16 Feb 2021.